Patricia A. Martin - Director at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
ANTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patricia A. Martin since 11 Mar 2025

Holdings reported by Patricia A. Martin for AN2 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,905 $19,609 $1.16 12 Jan 2026 Direct
Stock Option (Right to Buy) 20,400 20 Feb 2026 Direct Common Stock

Transactions reported by Patricia A. Martin for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.